OrbiMed’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Sell |
|
|||||
|
2025
Q1 | $41.9M | Hold |
|
|||||
|
2024
Q4 | $38.1M | Hold |
|
|||||
|
2024
Q3 | $23.7M | Hold |
|
|||||
|
2024
Q2 | $25.8M | Sell |
|
|||||
|
2024
Q1 | $52.9M | Hold |
|
|||||
|
2023
Q4 | $41.3M | Sell |
|
|||||
|
2023
Q3 | $39M | Hold |
|
|||||
|
2023
Q2 | $18M | Hold |
|
|||||
|
2023
Q1 | $18.6M | Hold |
|
|||||
|
2022
Q4 | $5.98M | Hold |
|
|||||
|
2022
Q3 | $15K | Hold |
|
|||||
|
2022
Q2 | $19.9K | Hold |
|
|||||
|
2022
Q1 | $32.9M | Hold |
|
|||||
|
2021
Q4 | $40.4M | Hold |
|
|||||
|
2021
Q3 | $63.6M | Hold |
|
|||||
|
2021
Q2 | $95.5M | Buy |
|